Drug and medical device maker Baxter International plans to buy the privately held Swedish company Gambro AB for $2.7 billion to broaden its dialysis product portfolio. Gambro makes products for patients with acute or …
Originally posted here:
Business news briefs | The Salt Lake Tribune